Kleist, Britta <br/><br/>
Correlation between DPYD gene variation and KRAS wild type status in colorectal cancer.  [electronic resource] 

 -  Journal of clinical pathology  Mar 2016 
 - 204-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1472-4146 
<br/><br/><label>Standard No.: </label>10.1136/jclinpath-2015-202903  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antimetabolites, Antineoplastic--adverse effects<br/>Colorectal Neoplasms--drug therapy<br/>DNA Mutational Analysis<br/>Dihydrouracil Dehydrogenase (NADP)--genetics<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Fluorouracil--adverse effects<br/>Gene Expression Profiling--methods<br/>Genetic Predisposition to Disease<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiplex Polymerase Chain Reaction<br/>Mutation<br/>Pharmacogenetics<br/>Phenotype<br/>Polymorphism, Genetic<br/>Precision Medicine<br/>Predictive Value of Tests<br/>Protein Kinase Inhibitors--therapeutic use<br/>Proto-Oncogene Proteins p21(ras)--genetics